mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.7 |